6533b7dbfe1ef96bd12708e4

RESEARCH PRODUCT

Change in measured Patient-Reported Outcomes in severe eosinophilic asthma patients treated with benralizumab under real life conditions in Germany (imPROve asthma study) – Study Design

Stephanie KornMarek LommatzschT GrundA ShavitH Watz

subject

Pediatricsmedicine.medical_specialtychemistry.chemical_compoundchemistrybusiness.industrymedicineEosinophilic asthmamedicine.diseaseBenralizumabbusinessAsthmahttps://doi.org/10.1055/s-0039-3403120